dabigatran has been researched along with axitinib in 1 studies
| Studies (dabigatran) | Trials (dabigatran) | Recent Studies (post-2010) (dabigatran) | Studies (axitinib) | Trials (axitinib) | Recent Studies (post-2010) (axitinib) |
|---|---|---|---|---|---|
| 3,887 | 261 | 3,490 | 765 | 145 | 683 |
| Protein | Taxonomy | dabigatran (IC50) | axitinib (IC50) |
|---|---|---|---|
| Serine/threonine-protein kinase PLK4 | Homo sapiens (human) | 0.045 | |
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | 0.0658 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.046 | |
| Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | 0.0001 | |
| Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | 0.0001 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.0079 | |
| Serine/threonine-protein kinase TBK1 | Homo sapiens (human) | 0.47 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertoletti, L; Bin, V; Delavenne, X; Hodin, S; Lafaie, L; Saïb, S | 1 |
1 other study(ies) available for dabigatran and axitinib
| Article | Year |
|---|---|
Tyrosine kinase inhibitors and direct oral anticoagulants: In vitro evaluation of drug-drug interaction mediated by P-glycoprotein.
Topics: Administration, Oral; Anticoagulants; ATP Binding Cassette Transporter, Subfamily B, Member 1; Axitinib; Crizotinib; Dabigatran; Drug Interactions; Humans; Imatinib Mesylate; Neoplasms; Protein Kinase Inhibitors; Pyrazoles; Pyridones; Rivaroxaban | 2022 |